L3VLUP
ProSign in

MSA · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

MSALLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • MSA
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterMSALLY
Q3 20204 holders, $493m33 holders, $14.1bn
Q4 20203 holders, $481m29 holders, $17.3bn
Q1 20213 holders, $246m24 holders, $23.0bn
Q2 20213 holders, $265m24 holders, $27.8bn
Q3 20213 holders, $229m31 holders, $29.9bn
Q4 20211 holders, $228m31 holders, $34.7bn
Q1 20221 holders, $197m24 holders, $35.3bn
Q2 20221 holders, $2.8m33 holders, $42.7bn
Q3 20221 holders, $1.3m31 holders, $43.4bn
Q4 20222 holders, $16m31 holders, $46.6bn
Q1 20232 holders, $30m33 holders, $44.3bn
Q2 20232 holders, $46m37 holders, $59.6bn
Q3 20231 holders, $35m44 holders, $67.6bn
Q4 20234 holders, $49m45 holders, $73.6bn
Q1 20247 holders, $294m41 holders, $95.3bn
Q2 20244 holders, $274m43 holders, $110bn
Q3 20244 holders, $248m45 holders, $107bn
Q4 20245 holders, $277m46 holders, $93.9bn
Q1 20256 holders, $247m42 holders, $98.4bn
Q2 20256 holders, $444m43 holders, $93.2bn
Q3 20255 holders, $385m39 holders, $86.7bn
Q4 20256 holders, $324m41 holders, $123bn
Q1 20267 holders, $354m39 holders, $106bn
Q2 20264 holders, $367m44 holders, $132bn
MSA

Msa Safety Inc

Holders
7
Reported value
$294m
Buyers
6
Sellers
0

Breadth +6 among 93 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
41
Reported value
$95.3bn
Buyers
15
Sellers
27

Breadth -12 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2024

Among the 43 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only MSA (2)

Baillie Gifford & Co, ExodusPoint Capital Management LP

Only LLY (36)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Invesco Ltd, Jane Street Group LLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, Point72 Asset Management LP, Polen Capital Management LLC, Renaissance Technologies LLC, and 11 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →